$2.55
0[0.00%]
At close: Apr 18
Armata Pharmaceuticals
(AMEX:ARMP)Armata Pharmaceuticals Stock (AMEX:ARMP), Analyst Ratings, Price Targets, Predictions
Armata Pharmaceuticals Inc has a consensus price target of $7, established from looking at the 5 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on March 22, 2024, August 14, 2023, and May 12, 2023. With an average price target of $7 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 180.00% upside for Armata Pharmaceuticals Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Armata Pharmaceuticals
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/22/2024 | ARMP | Buy Now | Armata Pharmaceuticals | $2.50 | 180% | HC Wainwright & Co. | Joseph Pantginis | $7 → $7 | Maintains | Buy | Get Alert |
| 08/14/2023 | ARMP | Buy Now | Armata Pharmaceuticals | $2.50 | 180% | HC Wainwright & Co. | Joseph Pantginis | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2023 | ARMP | Buy Now | Armata Pharmaceuticals | $2.50 | 180% | HC Wainwright & Co. | Joseph Pantginis | → $7 | Reiterates | Buy → Buy | Get Alert |
| 03/17/2023 | ARMP | Buy Now | Armata Pharmaceuticals | $2.50 | 180% | HC Wainwright & Co. | Joseph Pantginis | → $7 | Reiterates | → Buy | Get Alert |
| 03/07/2023 | ARMP | Buy Now | Armata Pharmaceuticals | $2.50 | 180% | HC Wainwright & Co. | Joseph Pantginis | → $7 | Reiterates | → Buy | Get Alert |
FAQ
What is the target price for Armata Pharmaceuticals (ARMP)?
The latest price target for Armata Pharmaceuticals (AMEX: ARMP) was reported by HC Wainwright & Co. on March 22, 2024. The analyst firm set a price target for $7.00 expecting ARMP to rise to within 12 months (a possible 174.51% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Armata Pharmaceuticals (ARMP)?
The latest analyst rating for Armata Pharmaceuticals (AMEX: ARMP) was provided by HC Wainwright & Co., and Armata Pharmaceuticals maintained their buy rating.
When was the last upgrade for Armata Pharmaceuticals (ARMP)?
There is no last upgrade for Armata Pharmaceuticals.
When was the last downgrade for Armata Pharmaceuticals (ARMP)?
There is no last downgrade for Armata Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Armata Pharmaceuticals (ARMP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Armata Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Armata Pharmaceuticals was filed on March 22, 2024 so you should expect the next rating to be made available sometime around March 22, 2025.
Is the Analyst Rating Armata Pharmaceuticals (ARMP) correct?
While ratings are subjective and will change, the latest Armata Pharmaceuticals (ARMP) rating was a maintained with a price target of $7.00 to $7.00. The current price Armata Pharmaceuticals (ARMP) is trading at is $2.55, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.